Zwart, Koen
van der Baan, Frederieke H.
Punt, Cornelis J. A.
Wensink, G. Emerens
Bolhuis, Karen
Laclé, Miangela M.
van Grevenstein, Wilhelmina M. U.
Hagendoorn, Jeroen
de Hingh, Ignace H.
Koopman, Miriam
Vink, Geraldine
Roodhart, Jeanine
Article History
Received: 28 April 2023
Accepted: 3 July 2023
First Online: 1 August 2023
Disclosures
: C.J.P.: Nordic Pharma. E.W.: None. F.v.d.B.: None. G.V.: BMS, Merck, Servier, Personal Genome Diagnostics, Bayer, Sirtex, Pierre Fabre, Lilly. I.d.H.: ROCHE, RanD Biotech. J.H.: None. J.R.: Bayer, BMS, Merck-Serono, Pierre Fabre, Servier, HUB4organoids, Cleara Biotech. K.B.: None. K.Z.: None. M.K.: Nordic Farma, Merck-Serono, Pierre Fabre, Servier, Bayer, Bristol Myers Squibb, Merck, Roche and Servier. M.L.: None. W.v.G.: None.